UD Talks

This episode of UD Talks dives into an essential and often under-discussed topic: sexual health. Joining our host Denis O’Driscoll is Jo Bergin, Candidate Advanced Nurse Practitioner in Sexual Health from the GUIDe Clinic at St. James’s Hospital. With years of experience, Jo brings a wealth of knowledge and practical insight into how pharmacists can better understand, protect, and help patients prioritise their sexual health. For more information or resources on Sexual Health and HIV call the HSE Helpline on 1800 459 459 The content of this podcast is intended for pharmacists, healthcare professionals, and individuals with a professional interest in community pharmacy. While every effort has been made to ensure the accuracy of the content within this podcast, United Drug cannot accept responsibility for any mistakes, errors, or inaccuracies. Listeners are strongly advised to verify the information contained in this podcast with a relevant healthcare provider or seek medical advice where appropriate before acting on any information provided. United Drug shall not be liable for any loss or damage arising from the use of the information contained in this podcast. This disclaimer operates to limit United Drug’s liability under contract, tort (including negligence), or statute. This disclaimer is provided to ensure that listeners are aware of the limitations of liability before they rely on the content. By continuing to listen to this podcast, listeners signify their assent to this disclaimer.

On this episode of UD Talks we’ll be tackling a critical and ongoing issue—Long Covid. With the pandemic’s immediate threat behind us, many people are still struggling with the long-term effects of the virus, facing lingering symptoms that affect their daily lives. Joining our host Denis O’Driscoll to shed light on this important topic are two experts in infectious diseases. Lorna Quigley, Programme Manager for Infectious Diseases at the HSE, and Dr. Stefano Savinelli, Clinical Lead for Infectious Diseases with the HSE. Together, they discuss the latest research, treatment options, and how pharmacists can support those affected by Long Covid. The content of this podcast is intended for pharmacists, healthcare professionals, and individuals with a professional interest in community pharmacy. While every effort has been made to ensure the accuracy of the content within this podcast, United Drug cannot accept responsibility for any mistakes, errors, or inaccuracies. Listeners are strongly advised to verify the information contained in this podcast with a relevant healthcare provider or seek medical advice where appropriate before acting on any information provided. United Drug shall not be liable for any loss or damage arising from the use of the information contained in this podcast. This disclaimer operates to limit United Drug’s liability under contract, tort (including negligence), or statute. This disclaimer is provided to ensure that listeners are aware of the limitations of liability before they rely on the content. By continuing to listen to this podcast, listeners signify their assent to this disclaimer.

For this episode, our host Denis O'Driscoll is joined by Joe Hughes & Karen Phoenix, founders of Lil Red's Legacy, a sepsis awareness campaign which they developed following the tragic death of their son Sean, aka Lil Red, in 2018 due to sepsis. Joe and Karen have pioneered the public awareness campaign surrounding sepsis and shared their lived experience of the signs and symptoms of sepsis.  Also joining Denis is Lorna Quigley, Programme Manager, National Infectious Diseases Programme, HSE and Michael O'Dwyer, Clinical Lead, National Programme for Sepsis, HSE.  Listen to them discuss signs and symptoms of sepsis, the role of the pharmacist in sepsis prevention and treatment, and potential technology for diagnosing sepsis in the future.  The content of this podcast is intended for pharmacists, healthcare professionals, and individuals with a professional interest in community pharmacy. While every effort has been made to ensure the accuracy of the content within this podcast, United Drug cannot accept responsibility for any mistakes, errors, or inaccuracies. Listeners are strongly advised to verify the information contained in this podcast with a relevant healthcare provider or seek medical advice where appropriate before acting on any information provided. United Drug shall not be liable for any loss or damage arising from the use of the information contained in this podcast. This disclaimer operates to limit United Drug’s liability under contract, tort (including negligence), or statute. This disclaimer is provided to ensure that listeners are aware of the limitations of liability before they rely on the content. By continuing to listen to this podcast, listeners signify their assent to this disclaimer.

For this episode, our host Denis O'Driscoll is joined by Jenny Smyth, Naloxone Project Lead with HSE Addiction Services. Listen to them discuss signs and symptoms of overdose, the use of Naloxone in overdose prevention and how pharmacists can access key learnings in overdose prevention.  The content of this podcast is intended for pharmacists, healthcare professionals, and individuals with a professional interest in community pharmacy. While every effort has been made to ensure the accuracy of the content within this podcast, United Drug cannot accept responsibility for any mistakes, errors, or inaccuracies. Listeners are strongly advised to verify the information contained in this podcast with a relevant healthcare provider or seek medical advice where appropriate before acting on any information provided. United Drug shall not be liable for any loss or damage arising from the use of the information contained in this podcast. This disclaimer operates to limit United Drug’s liability under contract, tort (including negligence), or statute. This disclaimer is provided to ensure that listeners are aware of the limitations of liability before they rely on the content. By continuing to listen to this podcast, listeners signify their assent to this disclaimer